Skip to content

Women's Health

Font Size

The Future of Breast Cancer Screening

An array of high-tech detection techniques and devices is on the scientific horizon.

Toward a Better Image (of Breasts) continued...


Researchers at Dartmouth College in New Hampshire are simultaneously studying four of these screening techniques: NIR, MIS, EIS, and MRE. If one or more of these methods are found to be promising, scientists might look into integrating the technologies into a single tool.

"We're excited about the possibilities, but there's a lot to be worked out," says Keith Paulsen, PhD, principal investigator of Dartmouth's Breast Imaging Project.


Clinical trials began April 2003, and may wrap up next summer. An interim analysis with official statistics on the success of each technique is due in the next couple of weeks; meantime, Paulsen is optimistic. "The projects are going well," he says.

Looking Into a Biological Crystal Ball

Several studies are currently looking into the possibility of diagnosing breast cancer at the cellular level. There is hope that someday researchers will be able to identify a turning point when biological substances become cancerous, thus leading to development of methods for detecting warning signals.

The National Cancer Institute alone has funded research into at least a half-dozen tests that involve examining typical and irregular proteins, molecules, genes, and other biological matter. One such large clinical trial in progress is a blood test. By analyzing concealed patterns of protein in blood, investigators propose being able to distinguish malignant tissues from benign ones.

Although this blood test is currently being tested only for ovarian cancer, researchers are hopeful the technology, once proven, could be adapted to other cancers. If everything goes well, investigators plan to compare the outcome of the trial with other blood test research around the country of other cancers.

One such study to detect breast cancer by looking at blood cells has already ended. The results? The blood test was 95% successful in spotting malignancies. The complete report is currently being reviewed for publication in a medical journal.

"Everything looks extremely exciting...but we want to move cautiously," says Lance Liotta, MD, PhD, a principal investigator of the Clinical Proteomics Program, and chief of the laboratory of pathology at the National Cancer Institute.

When could such a blood test become available? Liotta says that depends on three factors:

  • First, researchers must check the accuracy of the blood test by waiting to see if women develop cancer.
  • Second, those results must prove the test works reliably in large groups of women.
  • Third, the Food and Drug Administration must approve the test.

If all variables fall into place, however, he says the test could be on the market within the next 5 years -- unless competing private companies come up with the technology first.

How Better Screening Helps High-Risk Women

The technology to screen for genetic mutations is already available, but it is recommended only for women who have reason to believe they are at high risk for developing breast cancer, such as a strong family history.

Today on WebMD

hands on abdomen
Test your knowledge.
womans hand on abdomen
Are you ready for baby?
birth control pills
Learn about your options.
Is it menopause or something else?
Couple with troubles
Bone density illustration
Young woman being vaccinated
woman holding hand to ear

Send yourself a link to download the app.

Loading ...

Please wait...

This feature is temporarily unavailable. Please try again later.


Now check your email account on your mobile phone to download your new app.

Blood pressure check
mother and daughter talking
intimate couple
puppy eating